Global Next-Generation Antibody Therapeutics Market to Reach US $6,761.1 Million by 2022
Persistence Market Research (PMR) has recently announced the publication of a research report on the global next-generation antibody therapeutics market. According to the report, titled "Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody Products to Witness Highest Growth by 2022", the next-generation antibody therapeutics market is projected to expand at a healthy CAGR of 13% between 2014 and 2022 and reach a market value of US$6,761.1 million by 2022. For 2015, analysts at PMR have projected a market value...
View full press release